With obesity rates soaring, many experts have been lobbying for better regulation of the US ‘industrial food complex’ for ...

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply lower Friday, after President-elect Donald Trump named Robert F. Kennedy Jr.

The FDA has cleared the research organization's investigational new drug application, allowing it to start clinical tests of the experimental treatment DT2-SCT.

An advancement in diabetes treatment has been achieved by Professor Hyun-Wook Kang and his team from the Department of ...

New research, led by experts at the University of Nottingham, has found that certain types of medication used to treat ...

A new study supports the notion that the same mechanisms that help folks lose weight with Ozempic and its kin also work to ...

A recent study from the Federal University of São Paulo (UNIFESP) has found that using infrared light along with regular ...

A recent study from the University of Hong Kong has found that sodium-glucose cotransporter 2 inhibitors (SGLT2i), a new type ...

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...

Nearly three quarters of U.S. adults are overweight or obese, according to a sweeping new study. The findings have ...

The University of Pittsburgh is studying ways to improve the lives of Type 2 diabetics, or people who just want to control their sugar levels.

Hims & Hers introduced a new tracker to monitor shortages of GLP-1 weight loss and diabetes drugs, responding to the FDA's decision to end the compounded versions, Yahoo Finance reported Nov. 13.